Ocular Therapeutix (OCUL) announced that David Robinson has agreed to join the Company as Global Chief Commercial Officer. Prior to joining Ocular, Robinson served as Chief Marketing Officer, Global Ophthalmology at Merck (MRK)
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCUL:
- Unusually active option classes on open January 16th
- Sanofi prepping higher bid for Ocular Therapeutix, IBD reports
- Ocular Therapeutix rises 11.7%
- Ocular Therapeutix Enters Quiet Period Ahead of SOL-1 Milestone
- Strong Buy Rating for Ocular Therapeutix Backed by Enhanced Regulatory Pathway and Promising Axpaxli Trial Data